Literature DB >> 10443517

Disseminated intravascular coagulation in aortic aneurysms: assessment of consumption site using labeled-platelet scintigraphy.

Y Sakakibara1, T Takeda, M Hori, T Mitsui, H Ijima.   

Abstract

BACKGROUND: It is known that disseminated intravascular coagulation (DIC) may occur along with aortic aneurysms. To assess the localization of the active consumption site we performed 111In-oxine labeled platelet scintigraphy in patients with chronic aortic aneurysms.
METHODS: Images were obtained using 111In-oxine labeled autologous platelets in 45 patients. Planar images were taken twice (at 4 and 48 hrs) after injection. A visual inspection of the radioactivity uptake and special analysis in regions of interest were performed.
RESULTS: Thirty-five patients (78%) showed a focal accumulation of radioactivity in the aortic aneurysm. Six of 13 patients (46%) with dissecting aortic aneurysm, and 4 of 32 patients (12.5%) with true aneurysms were evaluated as negative uptake by scintigram (p < 0.05). The aneurysm/heart ratio was 0.85 +/- 0.16 (mean +/- SD) (4 hrs) and 1.09 +/- 0.15 (48 hrs) after injection; the aneurysm/liver ratio was 0.56 +/- 0.16 (4 hrs) and 0.38 +/- 0.09 (48 hrs); the aneurysm/spleen ratio was 0.39 +/- 0.07 (4 hrs) and 0.39 +/- 0.08 (48 hrs).
CONCLUSIONS: When the probability of DIC is clinically high in patients with aortic aneurysms, 111In-oxine labeled platelet scintigraphy provides useful preoperative information regarding the location of the functionally active consumption focus.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10443517     DOI: 10.1055/s-2007-1013133

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN: 0171-6425            Impact factor:   1.827


  2 in total

1.  Disseminated intravascular coagulation or extended intravascular coagulation in massive pulmonary embolism.

Authors:  M Levi
Journal:  J Thromb Haemost       Date:  2010-04-20       Impact factor: 5.824

2.  Phospholipid membranes drive abdominal aortic aneurysm development through stimulating coagulation factor activity.

Authors:  Keith Allen-Redpath; Maceler Aldrovandi; Sarah N Lauder; Anastasia Gketsopoulou; Victoria J Tyrrell; David A Slatter; Robert Andrews; W John Watkins; Georgia Atkinson; Eileen McNeill; Anna Gilfedder; Majd Protty; James Burston; Sam R C Johnson; Patricia R S Rodrigues; Dylan O Jones; Regent Lee; Ashok Handa; Keith Channon; Samya Obaji; Jorge Alvarez-Jarreta; Gerhard Krönke; Jochen Ackermann; P Vince Jenkins; Peter W Collins; Valerie B O'Donnell
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-03       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.